| Company type | Public |
|---|---|
| Industry | Biotechnology Chemicals Pharmaceuticals[1][2] |
| Founded | 1904 |
| Headquarters | Radnor, Pennsylvania, U.S. |
Key people | Michael Stubblefield (CEO and President) |
| Brands |
|
| Revenue | US$6.967 billion[3] (2024) |
| US$321 million[3] | |
| Owner | New Mountain Capital (10%) Funds advised by Goldman Sachs (13%)[4] |
Number of employees | 14,500 (December 2023)[5] |
| Website | avantorsciences |
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceuticals company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.